# Talicia (talicia) PDUFA date and FDA approval status

Canonical: https://sec-api.dev/pdufa/talicia

> Talicia (talicia), sponsored by RedHill Biopharma Ltd. (RDHL): 1 recorded catalyst.

Data as of November 16, 2026 (snapshot 20261116T222116Z). Every date quotes the SEC filing or FDA page it came from. Date precision: month only.

**Free:** every drug page and the next 30 days of the FDA calendar, no account. Calendar API, alerts when a date moves, and full history: https://sec-api.dev/pricing . Free API key: https://sec-api.dev/sign-up?ref=ai-claudebot

## Key facts

| Field | Value |
| --- | --- |
| Drug | Talicia (talicia) |
| Codes |  |
| Sponsor | RedHill Biopharma Ltd. (RDHL) https://sec-api.dev/companies/rdhl/catalysts |
| Indications |  |
| Modality |  |
| FDA designations | none disclosed |

## Timeline

### Sep 2023: label expansion decision

- Status: completed, approved. Date confidence: month.
- First seen 2025-04-10, last confirmed 2026-04-27.
- SEC Form 10-K (accession 0001104659-26-049055): "In September 2023, we announced that the FDA had approved our supplemental new drug application (sNDA) for Talicia®, allowing a change in dosing to a more flexible schedule, enabling patients to take Talicia® three times daily, at least 4 hours apart with food." https://www.sec.gov/Archives/edgar/data/1553846/000110465926049055/rdhl-20251231x20f.htm
- SEC Form 10-K (accession 0001558370-25-004648): "In September 2023, we announced that the FDA had approved our supplemental new drug application (sNDA) for Talicia®, allowing a change in dosing to a more flexible regimen, enabling patients to take Talicia® three times daily, at least 4 hours apart with food." https://www.sec.gov/Archives/edgar/data/1553846/000155837025004648/rdhl-20241231x20f.htm

## Feeds and downloads

- Subscribe (iCal): https://sec-api.dev/pdufa/talicia.ics
- Next 30 days as CSV: https://sec-api.dev/fda-calendar.csv . JSON: https://sec-api.dev/fda-calendar.json . All events (iCal): https://sec-api.dev/fda-calendar.ics
- New or moved PDUFA dates: https://sec-api.dev/pdufa-dates/feed.xml (RSS), https://sec-api.dev/pdufa-dates/feed.json (JSON Feed)
- FDA approvals: https://sec-api.dev/fda-approvals-today/feed.xml (RSS), https://sec-api.dev/fda-approvals-today/feed.json (JSON Feed)
- License: CC BY 4.0 for the public 30-day window (https://sec-api.dev/biotech/license.txt). Full history: https://sec-api.dev/pricing

## Cite this page

sec-api.dev. "Talicia (talicia) PDUFA date and FDA approval status." Biotech catalyst calendar, data as of November 16, 2026 (snapshot 20261116T222116Z). https://sec-api.dev/pdufa/talicia

```bibtex
@misc{secapidev_pdufa_talicia_20261116,
  title        = {Talicia (talicia) PDUFA date and FDA approval status},
  author       = {{sec-api.dev}},
  year         = {2026},
  month        = {nov},
  howpublished = {\url{https://sec-api.dev/pdufa/talicia}},
  note         = {Biotech catalyst calendar, data as of 2026-11-16, snapshot 20261116T222116Z. Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source.}
}
```

```json
{"type":"dataset","id":"secapidev_pdufa_talicia_20261116","title":"Talicia (talicia) PDUFA date and FDA approval status","publisher":"sec-api.dev","URL":"https://sec-api.dev/pdufa/talicia","issued":{"date-parts":[[2026,11,16]]},"version":"20261116T222116Z","license":"https://creativecommons.org/licenses/by/4.0/","note":"Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source."}
```

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Food and Drug Administration or the U.S. Securities and Exchange Commission. Dates are as stated by sponsors and FDA; the FDA can act before or after a target date. Not investment advice.
